HomeACC 2016Highlights ACC 2016

Highlights ACC 2016

      HOPE 3: Reducing LDL Improves Prognosis in Intermediate Risk Patients

      In a large cohort of intermediate risk patients with no known CAD, treatment with low doses of...

      ixCELL-DCM: Stem Cell Therapy Improves Outcomes in Patients with Heart Failure

      Enhanced autologous bone marrow stem cell therapy improves clinical cardiac events in patients with heart failure and...